Hepatocyte fatty acid accumulation occurs in the absence of PPARα in the liver, leading to reduced levels of proteins and enzyme genes involved in fatty acid metabolism (such as ACSL1), thereby initiating and progressing liver disease (69). This evidence concerns the gene ACSL1 and liver disorder.